Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Administration of Dexamethasone in High-risk Sepsis
NCT05136560Phase 2Completed
- Sponsor
- CHA University
- Start
- Mar 2022
- Primary completion
- Feb 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in sepsis, sponsored by CHA University. Started Mar 2022; status: completed.
02
Drugs
dexamethasone
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT05136560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05136560.